Literature DB >> 11776298

The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?

H H Versteeg1, M P Peppelenbosch, C A Spek.   

Abstract

Tissue factor, a 47 kDa membrane glycoprotein, lies at the basis of the extrinsic pathway of the coagulation cascade. Interaction of TF with factor VIIa results in the formation of fibrin from fibrinogen, thereby inducing the formation of a blood clot. In addition to this well-established role in blood coagulation, TF is associated with various other physiological processes such as sepsis, inflammation, angiogenesis, metastasis and atherosclerosis. The molecular basis of the latter events is slowly emerging. It has become clear that TF-FVIIa interaction elicits a variety of intracellular signalling events that may be implicated in these actions. These events include the sequential activation of Src-like kinases, MAP kinases, small GTPases and calcium signalling. How this progress in the understanding of TF associated signal transduction may generate answers as to the mechanism through which TF exerts it pleiotropic effects will be focus of this review.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11776298

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Tissue factor with age-related macular degeneration.

Authors:  Guan-Feng Wang; Xiu-Lan Zou
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

2.  Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.

Authors:  Abhishek Roy; Shabbir A Ansari; Kaushik Das; Ramesh Prasad; Anindita Bhattacharya; Suman Mallik; Ashis Mukherjee; Prosenjit Sen
Journal:  J Biol Chem       Date:  2017-05-18       Impact factor: 5.157

Review 3.  Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation.

Authors:  Eric W Holroyd; Robert D Simari
Journal:  Thromb Res       Date:  2010-02-24       Impact factor: 3.944

4.  Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy.

Authors:  Barbara Ruszkowska; Grażyna Gadomska; Liliana Bielis; Marzena Gruszka; Barbara Góralczyk; Danuta Rość; Grażyna Odrowąż-Sypniewska
Journal:  J Zhejiang Univ Sci B       Date:  2011-01       Impact factor: 3.066

5.  Asbestos induces tissue factor in Beas-2B human lung bronchial epithelial cells in vitro.

Authors:  Alexei Iakhiaev; Usha Pendurthi; Steven Idell
Journal:  Lung       Date:  2004       Impact factor: 2.584

6.  Low levels of activated factor VII in systemic sclerosis.

Authors:  Alessandro Volpe; Gian Luca Salvagno; Giuseppe Lippi; Paola Caramaschi; Martina Montagnana; Sabrina Canestrini; Antonio Carletto; Lisa Maria Bambara; Domenico Biasi; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

Review 7.  Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.

Authors:  E Donnellan; B Kevane; B R Healey Bird; F Ni Ainle
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

8.  Peroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages.

Authors:  G Chinetti-Gbaguidi; C Copin; B Derudas; N Marx; J Eechkoute; B Staels
Journal:  PPAR Res       Date:  2016-12-27       Impact factor: 4.964

Review 9.  Current advances and travails in islet transplantation.

Authors:  David M Harlan; Norma Sue Kenyon; Olle Korsgren; Bart O Roep
Journal:  Diabetes       Date:  2009-10       Impact factor: 9.461

Review 10.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.